期刊文献+

卵巢肿瘤患者外周血乙酰肝素酶测定及临床意义 被引量:2

Detection and Clinical Significance of Serum Heparanase in Malignant Ovarian Tumor
下载PDF
导出
摘要 目的:探讨卵巢肿瘤患者外周血乙酰肝素酶(Hpa)含量测定的临床价值。方法:选择经病理学检查确诊的卵巢肿瘤,采用酶联免疫吸附法(ELISA)检测51例卵巢恶性肿瘤患者血清标本,其中未接受治疗26例(恶性治疗前组)、术后16例(恶性术后组)、复发9例(复发组);17例卵巢良性肿瘤(良性组)及16例正常妇女(对照组)血清中Hpa的表达。并将其与患者临床病理关系及预后进行分析。结果:①恶性治疗前组血清中Hpa含量(39.00±7.26μg/L)显著高于良性组(32.36±6.17μg/L)及对照组(26.22±8.06μg/L),差异有高度统计学意义(P<0.01);复发组、恶性术后组血清中Hpa含量(35.89±4.48μg/L,33.85±6.96μg/L)均高于对照组,差异均有高度统计学意义(P<0.01),与良性组差异均无统计学意义(P>0.05)。卵巢恶性肿瘤患者术后血清Hpa含量明显低于术前(31.58±5.67μg/L与38.02±7.74μg/L),差异有统计学意义(P<0.05)。②卵巢恶性肿瘤患者血清Hpa含量与肿瘤的临床分期、组织学分化程度、腹水量和有无肝转移相关(P<0.05)。③ROC曲线Hpa取值31.59μg/L时,术前判断卵巢恶性肿瘤的敏感度为74.5%,特异度为75.0%。结论:Hpa的表达与卵巢恶性肿瘤的发生、发展有关。Hpa有望成为临床上判断卵巢恶性肿瘤的指标之一。 Objective:To explore the clinical significance of serum heparanase(Hpa) detection in patients with malignant ovarian tumors.Methods:The serum heparanase(Hpa) was detected by enzyme-linked immunosorbent assay in 51 cases of ovarian cancers confirmed by pathology,in which 26 cases were without any treatment(malignant preoperation) ,16 cases were after operation(malignant postoperation) ,9 cases were recurrence(recurrence group) ,17 cases were with ovarian benign tumors(begin group) and 16 cases were normal controls(control group) . The relationship between the serum heparanase(Hpa) and clinical pathology as well as prognosis was analyzed.Results:The serum levels of the Hpa in malignant preoperation group(39.00±7.26 μg/L) were significantly higher than that in the benign group(32.36±6.17 μg/L) and control group(26.22±8.06 μg/L)(P0.01) . The serum levels of the Hpa were significantly higher in recurrent group(35.89±4.48 μg/L) and malignant postoperation group(33.85±6.96 μg/L) than that in control group(P0.01) ,but no significant difference to benign group(P0.05) . The serum levels of the Hpa in malignant ovarian tumor were significantly higher in pre-operation than that in post-operation(38.02±7.74 μg/L,31.58±5.67 μg/L)(P0.05) ②The serum level of Hpa in ovarian cancer was associated with tumor clinical stage,tumor pathological grade,ascitic fluid amount and metastasis(P0.05) ,but there was no relationship between the serum contain of heparanase(Hpa) and histotypes,lymph node and omentum metastasis(P0.05) .③ The ROC curve showed when heparanase(Hpa) value was 31.59 g/L,the sensitivity and specificity to determine invasion and metastasis of malignant ovarian tumors preoperatively was 74.5% and 75.0% respectively.Conclusions:The expression of Hpa is correlated with carcinogenesis and progress of ovarian cancer and is expected to become as indicators for judging invasion and metastasis.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2011年第10期762-766,共5页 Journal of Practical Obstetrics and Gynecology
关键词 卵巢 肿瘤 乙酰肝素酶 Ovarian Cancer Heparanase
  • 相关文献

参考文献6

  • 1Kim AW,Xu X, Hollinger EF, et al. Human heparanase-1 gene ex- pression in pancreatic adenocarcinoma[ J ]. J Gastrointest Surg,2002, 6(2) :167 - 172.
  • 2Maxhimer JB, Quiros RM, Stewart R, et al. Heparanase-1 expression is associated with the metastatic potential of breast cancer[ J]. Surger- y ,2002,132 (3) :326 - 333.
  • 3Quiros RM,Rao G,Plate J,et al. Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival [ J ]. Cancer,2006,106 ( 3 ) :532 - 540.
  • 4Tang W, Nakamura Y, Tsujimoto M, et al. Heparanase : a key enzyme in invasion and metastasis of gastric carcinoma [ J ]. Mod Pathol, 2002,15(4) :593 -598.
  • 5崔红梅,王海琳.乙酰肝素酶在妇科肿瘤中的研究进展[J].国外医学(妇产科学分册),2005,32(6):371-373. 被引量:3
  • 6Quiros RM, Rao G, Plate J, et al. Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival [J]. Cancer,2006,106(3):532 -540.

二级参考文献20

  • 1Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase:gene cloning, expression and function in tumor progression and metastasis. Nat Med,1999, 5(7):793-802.
  • 2Vlodavsky I, Goldshmidt O, Zcharia E,et al. Mammalian heparanase:involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol, 2002,12(2): 121-129.
  • 3Flonia LA, Miao HQ, Robert L, et al. Heterodimer formation is Essential for heparanase enzymatic activity. Biochem Biophys Res Commun, 2003,308(7): 885-891.
  • 4Boyd DD, Nakajima M. Involvement of heparanase in tumor metastasis:a new target in cancer therapy? Natl Cancer Inst,2004,96(16):1194-1195.
  • 5Oqishima T, Shiina H, Breault JE, et al. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer. Oncogene, 2005,78(5):667-674.
  • 6Temkin V, Aingon H, Puxeddu I, et al. Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. J Allergy Clin Immunol,2004,113(4):703-711.
  • 7Cohen E, Atzmon R,Vlodavxky I, et al. Heparanase processing by lysosomal/endosomal protein preparation. FEBS Lett, 2005, 579(11):2334-2338.
  • 8McKenzie E, Tyson K, Stamos A, et al. Cloning and expression profiling of Heparanase2, a novel mammalian heparanase family member. Biochem Biophys Res Commun, 2000, 276(3):1170-1177.
  • 9Sato T,Yamaquchi A, Goi T, et al. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis,hematogenous metastasis, and prognosis. Surg Oncol, 2004, 87 (4):174-181.
  • 10Edovitsky E, Elkin M, Zcharia E, et al. Heparanase gene silencing,tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst,2004,96(16): 1219-1230.

共引文献2

同被引文献18

  • 1Zheng L, Jiang G, Mei H, et al. Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells [J]. BMC Cancer,2010,5 (10):33. DOI:10.1186/1471-2407-10-33.
  • 2Lee TI, Yang HJ, Lin SY, et al.,The accuracy of fine-needle aspi- ration biopsy and frozen section in patients with thyroid cancer[J]. Thyroid,2002,12 (7):619-626. DOI:10.1089/105072502320288492.
  • 3Baloeh ZW, Fleisher S, LiVolsi VA, et al. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology [J]. Diagn Cytopathol,2002,26(1):41-44. DOI:10.1002/de.10043.
  • 4Alaedeen DI, Khiyami A, MeHenry C1L Fine-needle aspiration biop- sy specimen with a predominance of Htirthle cells: a dilemma in the management of nodular thyroid disease[J]. Surgery,2005,138 (4):650-657. DOI:http://dx.doi.org/10.1016/j.surg.2005.06.047.
  • 5Raman K, Kuberan B. Chemical tumor biology of heparan sulfate proteoglyeans[J]. Curr Chem Biol,2010,4(1):20-31. DOI:10.2174/ 187231310790226206.
  • 6Ziolkowski AF, Popp SK, Freeman C, et al. Heparan sulfate and hep- aranase play key roles in mouse β cell survival and autoimmune di- abetes[J]. J Clin Invest2012,122(1 ):132-141. DOI:10.1172/JCI46177.
  • 7Hoffmann AC, Moil R, Vallbohmer D, et al. High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adeno- carcinomas and correlated to PDGFA and via HIFIa to HB-EGF and bFGF[J]. J Gastrointest Surg,2008,12(10):1674-1682. DOI: 10.1007/s 11605-008-0628-2.
  • 8Tang D, Piao Y, Zhao S, et al. Expression and correlation of ma- trix metalloproteinase-9 and heparanase in patients with breast cancer[J].Med Oncol,2014,31 (7):26. DOI:10.1007/s12032-014- 0026-4.
  • 9Zhang W, Yang HC, Wang Q, et al. Clinical value of combined de- tection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis [J]. Anticancer Res,2011,31 (10) :3423-3428. DOI: 10.1007/sl 1670- 012-0067-1.
  • 10张晓勇,米淑玲,尹利荣,郭素杰,时扬.30岁以下卵巢肿瘤患者223例临床分析[J].国际妇产科学杂志,2009,36(2):158-160. 被引量:4

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部